ReviewTherapeutics and clinical risk management2016
Retargeting the management of hypercholesterolemia - focus on evolocumab.
Alessandro Colletti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it